Search Results - "Lango, M N"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy by DONOHUE, T. J, DWORKIN, L. D, LANGO, M. N, FLIEGNER, K, LANGO, R. P, BENSTEIN, J. A, SLATER, W. R, CATANESE, V. M

    Published in Circulation (New York, N.Y.) (01-02-1994)
    “…Left ventricular hypertrophy is a generalized adaptation to increased afterload, but the growth factors mediating this response have not been identified. To…”
    Get full text
    Conference Proceeding Journal Article
  2. 2
  3. 3

    An allelotype of papillary thyroid cancer by Califano, Joseph A., Johns, Michael M., Westra, William H., Lango, Miriam N., Eisele, David, Saji, Motoyasu, Zeiger, Martha A., Udelsman, Robert, Koch, Wayne M., Sidransky, David

    Published in International journal of cancer (20-12-1996)
    “…Although papillary carcinoma accounts for approximately 70% of all thyroid cancers, preliminary studies of allelic loss have thus far not identified any areas…”
    Get full text
    Journal Article
  4. 4

    Gastrin-Releasing Peptide Receptor-Mediated Autocrine Growth in Squamous Cell Carcinoma of the Head and Neck by Lango, Miriam N., Dyer, Kevin F., Lui, Vivian Wai Yan, Gooding, William E., Gubish, Christopher, Siegfried, Jill M., Grandis, Jennifer Rubin

    “…Background: Gastrin-releasing peptide receptor (GRPR)-mediated autocrine growth appears to be an early marker of susceptibility to tobacco-related lung…”
    Get full text
    Journal Article
  5. 5

    Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines by Song, J I, Lango, M N, Hwang, J D, Drenning, S D, Zeng, Q, Lamph, W W, Grandis, J R

    Published in Cancer research (Chicago, Ill.) (01-08-2001)
    “…Clinical studies have demonstrated that retinoids, including retinol (Vitamin A) and its synthetic derivatives, can eradicate leukoplakia and suppress the…”
    Get full text
    Journal Article
  6. 6

    TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo by Endo, S, Zeng, Q, Burke, N A, He, Y, Melhem, M F, Watkins, S F, Lango, M N, Drenning, S D, Huang, L, Rubin Grandis, J

    Published in Gene therapy (01-11-2000)
    “…Unlike normal mucosal squamous epithelial cells, head and neck squamous cell carcinomas (HNSCCs) overexpress TGF-alpha mRNA and protein which is required to…”
    Get full text
    Journal Article
  7. 7

    Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer by Lango, Miriam N, Shin, Dong Moon, Grandis, Jennifer Rubin

    Published in Current opinion in oncology (01-05-2001)
    “…Tyrosine kinase (type 1) growth factor receptors include the erbB family. These cell surface receptors were discovered in the context of cellular…”
    Get full text
    Journal Article
  8. 8

    Discordant, organ-specific regulation of insulin-like growth factor-I messenger ribonucleic acid in insulin-deficient diabetes in rats by Catanese, V M, Sciavolino, P J, Lango, M N

    Published in Endocrinology (Philadelphia) (01-02-1993)
    “…Linear growth retardation is common in uncontrolled insulin-deficient diabetes, but individual organs such as kidney may hypertrophy. To explore whether this…”
    Get more information
    Journal Article
  9. 9

    Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I by Donohue, T J, Dworkin, L D, Ma, J, Lango, M N, Catanese, V M

    Published in Journal of investigative medicine (01-12-1997)
    “…Left ventricular hypertrophy (LVH) is a generalized adaptation to altered myocardial load. Hypertension induces significant increases in ventricular IGF-I gene…”
    Get full text
    Journal Article
  10. 10

    Otolaryngology-Related Disorders in Underserved Populations, Otolaryngology Training and Workforce Considerations in North America by Westerberg, Brian D., MD, MHSc, FRCSC, Lango, Miriam N., MD

    Published in Otolaryngologic clinics of North America (01-06-2018)
    “…In North America, underserved and vulnerable populations experience poorer health outcomes despite greater per capita health care expenditures. Biologic,…”
    Get full text
    Journal Article
  11. 11

    TGF-[alpha] antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo by Endo, S, Zeng, Q, Burke, N A, Y He, Melhem, M F, Watkins, S F, Lango, M N, Drenning, S D, Huang, L, J Rubin Grandis

    Published in Gene therapy (01-11-2000)
    “…Unlike normal mucosal squamous epithelial cells, head and neck squamous cell carcinomas (HNSCCs) overexpress TGF-alpha mRNA and protein which is required to…”
    Get full text
    Journal Article
  12. 12

    Multimodal Treatment for Head and Neck Cancer by Lango, Miriam N., MD

    Published in The Surgical clinics of North America (01-02-2009)
    “…Head and neck cancers are relatively less common tumors, but with complex anatomic and physiologic relationships to the structures from which they arise…”
    Get full text
    Journal Article
  13. 13

    Controversies in Surgical Management of the Node-Positive Neck After Chemoradiation by Lango, Miriam N., MD, Myers, Jeffrey N., MD, PhD, Garden, Adam S., MD

    Published in Seminars in radiation oncology (2009)
    “…The addition of chemotherapy to radiation in the treatment of advanced-staged head and neck cancer has improved local-regional control and increased complete…”
    Get full text
    Journal Article
  14. 14